Do analysts rate DRMA or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to DRMA or ATPC?

In the previous week, Dermata Therapeutics had 1 more articles in the media than Agape ATP. MarketBeat recorded 3 mentions for Dermata Therapeutics and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.40 beat Dermata Therapeutics' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dermata Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SNYR or ATPC?

Synergy CHC presently has a consensus price target of $6.25, suggesting a potential upside of 6,094.25%. Given Synergy CHC's stronger consensus rating and higher probable upside, equities analysts clearly believe Synergy CHC is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNYR or ATPC more profitable?

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Agape ATP -85.94% -5.47% -4.94%

Does the media refer more to SNYR or ATPC?

In the previous week, Synergy CHC had 2 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for Synergy CHC and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.40 beat Synergy CHC's score of 0.36 indicating that Agape ATP is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synergy CHC 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Agape ATP 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate WNW or ATPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Meiwu Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, WNW or ATPC?

Agape ATP has lower revenue, but higher earnings than Meiwu Technology. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Meiwu Technology $7.08M 9.07 -$18.59M N/A N/A Agape ATP $1.52M 1.61 -$2.28M -$0.74 N/A

Do analysts rate ATPC or DSYWW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Big Tree Cloud 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, ATPC or DSYWW?

Big Tree Cloud has higher revenue and earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.61 -$2.28M -$0.74 N/A Big Tree Cloud $2.02M N/A N/A N/A N/A

Do analysts prefer ATPC or DRMAW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dermata Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, ATPC or DRMAW?

Dermata Therapeutics has lower revenue, but higher earnings than Agape ATP. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agape ATP $1.52M 1.61 -$2.28M -$0.74 N/A Dermata Therapeutics N/A N/A N/A N/A N/A

Does the media prefer ATPC or DRMAW?

In the previous week, Agape ATP had 1 more articles in the media than Dermata Therapeutics. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Dermata Therapeutics. Agape ATP's average media sentiment score of 0.40 beat Dermata Therapeutics' score of 0.00 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dermata Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Agape ATP (ATPC) Competitors

$2.45 -0.02 (-0.81%)

As of 08/21/2026 04:00 PM Eastern

Compare

ATPC vs. DRMA, SNYR, WNW, DSYWW, and DRMAW

Should you buy Agape ATP stock or one of its competitors? Agape ATP's main competitors and comparable companies include Dermata Therapeutics (DRMA), Synergy CHC (SNYR), Meiwu Technology (WNW), Big Tree Cloud (DSYWW), and Dermata Therapeutics (DRMAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Agape ATP compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Dermata Therapeutics has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

Agape ATP has higher revenue and earnings than Dermata Therapeutics. Agape ATP is trading at a lower price-to-earnings ratio than Dermata Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A
Agape ATP	$1.52M	1.61	-$2.28M	-$0.74	N/A

8.7% of Dermata Therapeutics shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 21.9% of Dermata Therapeutics shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Dermata Therapeutics had 1 more articles in the media than Agape ATP. MarketBeat recorded 3 mentions for Dermata Therapeutics and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.40 beat Dermata Therapeutics' score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dermata Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agape ATP	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Dermata Therapeutics has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Agape ATP's return on equity of -5.47% beat Dermata Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-166.66%	-130.13%
Agape ATP	-85.94%	-5.47%	-4.94%

Summary

Dermata Therapeutics and Agape ATP tied by winning 6 of the 12 factors compared between the two stocks.

How does Agape ATP compare to Synergy CHC?

Synergy CHC (NASDAQ:SNYR) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Agape ATP	-85.94%	-5.47%	-4.94%

0.0% of Agape ATP shares are held by institutional investors. 32.9% of Synergy CHC shares are held by company insiders. Comparatively, 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Synergy CHC has a beta of -0.14, indicating that its stock price is 114% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

Synergy CHC presently has a consensus price target of $6.25, suggesting a potential upside of 6,094.25%. Given Synergy CHC's stronger consensus rating and higher probable upside, equities analysts clearly believe Synergy CHC is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Agape ATP has lower revenue, but higher earnings than Synergy CHC. Agape ATP is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.05	-$12.34M	-$1.40	N/A
Agape ATP	$1.52M	1.61	-$2.28M	-$0.74	N/A

In the previous week, Synergy CHC had 2 more articles in the media than Agape ATP. MarketBeat recorded 4 mentions for Synergy CHC and 2 mentions for Agape ATP. Agape ATP's average media sentiment score of 0.40 beat Synergy CHC's score of 0.36 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synergy CHC	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Agape ATP	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Synergy CHC beats Agape ATP on 9 of the 16 factors compared between the two stocks.

How does Agape ATP compare to Meiwu Technology?

Meiwu Technology (NASDAQ:WNW) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

In the previous week, Agape ATP had 2 more articles in the media than Meiwu Technology. MarketBeat recorded 2 mentions for Agape ATP and 0 mentions for Meiwu Technology. Agape ATP's average media sentiment score of 0.40 beat Meiwu Technology's score of 0.00 indicating that Agape ATP is being referred to more favorably in the news media.

Company	Overall Sentiment
Meiwu Technology	Neutral
Agape ATP	Neutral

0.3% of Meiwu Technology shares are held by institutional investors. Comparatively, 0.0% of Agape ATP shares are held by institutional investors. 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Meiwu Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Meiwu Technology has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

Agape ATP has lower revenue, but higher earnings than Meiwu Technology.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Meiwu Technology	$7.08M	9.07	-$18.59M	N/A	N/A
Agape ATP	$1.52M	1.61	-$2.28M	-$0.74	N/A

Meiwu Technology has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Meiwu Technology's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Meiwu Technology	N/A	N/A	N/A
Agape ATP	-85.94%	-5.47%	-4.94%

Summary

Meiwu Technology beats Agape ATP on 7 of the 11 factors compared between the two stocks.

How does Agape ATP compare to Big Tree Cloud?

Agape ATP (NASDAQ:ATPC) and Big Tree Cloud (NASDAQ:DSYWW) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Big Tree Cloud	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Agape ATP had 2 more articles in the media than Big Tree Cloud. MarketBeat recorded 2 mentions for Agape ATP and 0 mentions for Big Tree Cloud. Agape ATP's average media sentiment score of 0.40 beat Big Tree Cloud's score of 0.00 indicating that Agape ATP is being referred to more favorably in the media.

Company	Overall Sentiment
Agape ATP	Neutral
Big Tree Cloud	Neutral

Big Tree Cloud has higher revenue and earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.61	-$2.28M	-$0.74	N/A
Big Tree Cloud	$2.02M	N/A	N/A	N/A	N/A

0.0% of Agape ATP shares are held by institutional investors. 2.0% of Agape ATP shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Big Tree Cloud has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Big Tree Cloud's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-85.94%	-5.47%	-4.94%
Big Tree Cloud	N/A	N/A	N/A

Summary

Agape ATP beats Big Tree Cloud on 5 of the 9 factors compared between the two stocks.

How does Agape ATP compare to Dermata Therapeutics?

Agape ATP (NASDAQ:ATPC) and Dermata Therapeutics (NASDAQ:DRMAW) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

0.0% of Agape ATP shares are owned by institutional investors. 2.0% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Agape ATP had 1 more articles in the media than Dermata Therapeutics. MarketBeat recorded 2 mentions for Agape ATP and 1 mentions for Dermata Therapeutics. Agape ATP's average media sentiment score of 0.40 beat Dermata Therapeutics' score of 0.00 indicating that Agape ATP is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agape ATP	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Dermata Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dermata Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Dermata Therapeutics has a net margin of 0.00% compared to Agape ATP's net margin of -85.94%. Dermata Therapeutics' return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agape ATP	-85.94%	-5.47%	-4.94%
Dermata Therapeutics	N/A	N/A	N/A

Dermata Therapeutics has lower revenue, but higher earnings than Agape ATP.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agape ATP	$1.52M	1.61	-$2.28M	-$0.74	N/A
Dermata Therapeutics	N/A	N/A	N/A	N/A	N/A

Summary

Agape ATP beats Dermata Therapeutics on 6 of the 9 factors compared between the two stocks.

Get Agape ATP News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATPC vs. The Competition

Export

Metric	Agape ATP	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$2.45M	$23.48B	$15.97B	$12.83B
Dividend Yield	N/A	4.29%	3.21%	10.78%
P/E Ratio	-3.31	19.22	13.58	24.21
Price / Sales	1.61	13.25	262,949.31	94.86
Price / Cash	N/A	17.15	56.19	36.90
Price / Book	0.11	3.00	4.98	6.42
Net Income	-$2.28M	$1.13B	$836.78M	$348.89M
7 Day Performance	-1.61%	0.71%	0.26%	0.08%
1 Month Performance	-5.04%	2.24%	2.22%	3.88%
1 Year Performance	-96.29%	-18.64%	13.47%	16.98%

Agape ATP Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATPC Agape ATP	0.4301 of 5 stars	$2.45 -0.8%	N/A	-96.3%	$2.45M	$1.52M	N/A	40	News Coverage Earnings Report Analyst Forecast
DRMA Dermata Therapeutics	0.9297 of 5 stars	$1.47 +2.8%	$10.00 +580.3%	-74.1%	$5.75M	N/A	N/A	8	News Coverage
SNYR Synergy CHC	2.654 of 5 stars	$0.11 -1.0%	$6.25 +5,741.1%	-96.6%	$1.63M	$30.38M	N/A	40	News Coverage Positive News Gap Up
WNW Meiwu Technology	0.1593 of 5 stars	$2.56 -1.5%	N/A	-98.6%	$410K	$7.08M	N/A	50
DSYWW Big Tree Cloud	N/A	$0.02 -18.4%	N/A	-6.8%	$0.00	$2.02M	N/A	82	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATPC) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agape ATP (ATPC) Competitors

ATPC vs. DRMA, SNYR, WNW, DSYWW, and DRMAW

How does Agape ATP compare to Dermata Therapeutics?

Summary

How does Agape ATP compare to Synergy CHC?

Summary

How does Agape ATP compare to Meiwu Technology?

Summary

How does Agape ATP compare to Big Tree Cloud?

Summary

How does Agape ATP compare to Dermata Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agape ATP (ATPC) Competitors

ATPC vs. DRMA, SNYR, WNW, DSYWW, and DRMAW

How does Agape ATP compare to Dermata Therapeutics?

Do analysts rate DRMA or ATPC?

Which has more volatility and risk, DRMA or ATPC?

Which has higher valuation & earnings, DRMA or ATPC?

Do insiders and institutionals hold more shares of DRMA or ATPC?

Does the media refer more to DRMA or ATPC?

Is DRMA or ATPC more profitable?

Summary

How does Agape ATP compare to Synergy CHC?

Is SNYR or ATPC more profitable?

Do insiders & institutionals hold more shares of SNYR or ATPC?

Which has more risk & volatility, SNYR or ATPC?

Do analysts rate SNYR or ATPC?

Which has preferable earnings and valuation, SNYR or ATPC?

Does the media refer more to SNYR or ATPC?

Summary

How does Agape ATP compare to Meiwu Technology?

Does the media prefer WNW or ATPC?

Do institutionals and insiders hold more shares of WNW or ATPC?

Do analysts rate WNW or ATPC?

Which has more volatility & risk, WNW or ATPC?

Which has stronger valuation and earnings, WNW or ATPC?

Is WNW or ATPC more profitable?

Summary

How does Agape ATP compare to Big Tree Cloud?

Do analysts rate ATPC or DSYWW?

Does the media prefer ATPC or DSYWW?

Which has better valuation & earnings, ATPC or DSYWW?

Do institutionals & insiders hold more shares of ATPC or DSYWW?

Is ATPC or DSYWW more profitable?

Summary

How does Agape ATP compare to Dermata Therapeutics?

Do insiders & institutionals believe in ATPC or DRMAW?

Does the media prefer ATPC or DRMAW?

Do analysts prefer ATPC or DRMAW?

Is ATPC or DRMAW more profitable?

Which has preferable earnings & valuation, ATPC or DRMAW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATPC vs. The Competition

Agape ATP Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools